CGON: POST LEONARD E discloses securities transactions
By AlphaYouPublished Form 4
POST LEONARD E
Reporting filer
POST LEONARD E reported Exercise or conversion in CG Oncology, Inc.: 1000 units of Common Stock, dated 2026-09-15. The full Form 4 contains 3 transaction entries.
- Disclosed
- Sep 17, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | POST LEONARD E | 2026-09-15 | M | Exercise or conversion | 1000 | 0.6 | 1,000 | 2 days | Filed terms
|
| Common Stock | POST LEONARD E | 2026-09-15 | S | Sale | 1000 | 72.98 | 0 | 2 days | Filed terms
|
| Director Stock Option (right to buy) (derivative) | POST LEONARD E | 2026-09-15 | M | Exercise or conversion | 1000 | 0 | 103,077 | 2 days | Filed terms
|
Common Stock
- Owner
- POST LEONARD E
- Date
- 2026-09-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1000
- Price
- 0.6
- Following holdings
- 1,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 1000
- transaction Price Per Share: 0.6
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 1000
- direct Or Indirect Ownership: D
Common Stock
- Owner
- POST LEONARD E
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 1000
- Price
- 72.98
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 1000
- transaction Price Per Share: 72.98
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Director Stock Option (right to buy) (derivative)
- Owner
- POST LEONARD E
- Date
- 2026-09-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1000
- Price
- 0
- Following holdings
- 103,077
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Director Stock Option (right to buy)
- conversion Or Exercise Price: 0.6
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 1000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F3
- expiration Date: 2028-07-08
- underlying Security Title: Common Stock
- underlying Security Shares: 1000
- shares Owned Following Transaction: 103077
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- POST LEONARD E: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.54 to $73.52 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3: Fully vested
Original sources
Prepared automatically from public filing data. Report a correction.